Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
Sign-in required.
Sign in
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
Close
Site logo
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
MENU
Site logo
About Us
Pharmacometrics
Services
News
Contact Us
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Check out our press releases, events,
and learning sessions!
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
K
-BIO
R&
D
News
Updates and news
티움바이오, 자궁내막증 치료제 후보 'TU2670' 러시아 임상2a상 승인 [2020.10.13]
0
0
16 Oct 2020
Views
734
Updates and news
GC녹십자, 희귀질환치료제 '헌터라제' 중국 허가 [2020.09.09]
0
0
9 Sep 2020
Views
1025
Updates and news
이수앱지스, '솔리리스 시밀러' 뉴질랜드·호주 1상 종료 [2020.08.19]
0
0
20 Aug 2020
Views
926
Updates and news
[단독]얀센, '유한 레이저티닙' 글로벌 3상임상 착수[2020.07.29]
0
0
20 Aug 2020
Views
1024
Updates and news
이수앱지스, 유럽종양학회서 `ISU104’ 임상1상 결과 공개 [2020.07.20]
0
0
20 Aug 2020
Views
781
Updates and news
식약처, 코로나19 항체치료제 ‘CT-P59’ 임상1상 승인[2020.07.17]
0
0
20 Aug 2020
Views
851
Updates and news
티움바이오,자궁내막증치료제 유럽 2a상 임상시험계획 신청[2020.07.17]
0
0
20 Aug 2020
Views
819
Updates and news
서정진 "코로나 치료제 내년 1분기 허가 완료…500만명분 만들 것" [2020.06.23]
0
0
20 Aug 2020
Views
732
Updates and news
에이비온, C-Met억제제 ‘ABN401’ 전임상 결과 논문 발표 [2020.06.17]
0
0
20 Aug 2020
Views
779
Previous
1
2
3
4
5
Next
